期刊文献+

婴儿双歧杆菌介导的CD/5-FC自杀基因系统对黑色素瘤的抑瘤实验 被引量:6

Antitumor Efficacy of CD/5-FC Suicide Gene Therapy System Mediated by Bifidobacterium Infantis against Melanoma
下载PDF
导出
摘要 目的 观察婴儿双歧杆菌介导的胞嘧啶脱氨酶 / 5 -氟胞嘧啶 (CD/ 5 - FC)自杀基因系统对黑色素瘤的体内、外抑瘤效果。方法 含重组 CD基因的婴儿双歧杆菌中加入 5 - FC,厌氧条件下培养 2 4 h后取其上清液 ,加到黑色素瘤 B16 - F10细胞上 ,观察其对细胞形态及细胞生长抑制率的影响 ;建立小鼠黑色素瘤动物模型 ,尾静脉注入含重组 CD基因的婴儿双歧杆菌 ,腹腔注入 5 - FC,观察携带重组 CD基因的婴儿双歧杆菌联合 5 - FC对黑色素瘤肿瘤体积及肿瘤体积倍增时间的影响。结果  1体外实验 :实验组肿瘤细胞形态显示出显著的损伤性改变 ,细胞生长受到明显抑制 ,而对照组肿瘤细胞影响不大。 2小鼠黑色素瘤动物模型实验结果显示 ,经重组婴儿双歧杆菌联合 5 -FC治疗 2 1d,实验组肿瘤倍增时间明显长于对照组 ,其肿瘤体积明显小于对照组 ,且随着观察时间的延长 ,这种差异越显著。结论 婴儿双歧杆菌介导的 CD/ 5 - FC自杀基因系统对黑色素瘤具有明显的抑瘤效果。 Objective To observe the antitumor efficacy of cytosine deaminase/5-fluorocytosine(CD/5-FC )suicide gene therapy system mediated by Bifidobacterium Infantis against melanoma in vitro and in vivo. Methods Bifidobacterium Infantis transfected by CD gene was incubated with 5-FC in anaerobic condition. The supernatant of bacteria was collected and added to the melanoma B16-F10 cells for assessment of the killing effect of this suicide gene system. Mice were inocubated with melanoma B16-F10 cells to establish animal models. Then the mice bearing melanoma were treated by a combination of Bifidobacterium Infantis transfected by CD gene and 5-FC. Bifidobacterium Infantis transfected by CD gene was injected into the tail vein of mice and 5-FC was given introperitoneally. Results ① in vitro, the tumor cells in test groups appeared damaged with remarkable changes in morphology, and the cell growth was significantly inhibited as compared against those in the control group. ② In animal experiment, after the mice melanoma model being treated with the recombined bacteria and 5-FC for 21 days, the tumor growth span was remarkably prolonged and the tumor volume was significantly inhibited when compared with control. The differences became more obvious with the passage of observation time. Conclusion CD/5-FC suicide gene therapy system mediated by Bifidobacterium Infantis was noted to have good antitumor effect on melanoma.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2005年第2期165-168,共4页 Journal of Sichuan University(Medical Sciences)
基金 纽约中华医学基金会 (CMB MERF-2 0 0 2 )资助
关键词 婴儿双歧杆菌 胞嘧啶脱氨酶 5-氟胞嘧啶 基因治疗 Bifidobacterium infantis Cytosine deaminase 5-fluorocytosine Gene therapy
  • 相关文献

参考文献9

  • 1Miyagi T, Koshida K, Hori O, et al. Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system. J Gene Med, 2003;5(1):30.
  • 2Brown NL, Lemoine NR. Clinical trials with GDEPT: cytosine deaminase and 5-fluorocytosine. Methods Mol Med, 2004;90(2):451.
  • 3郭志英,易成,王树人,王浩毅.婴儿双歧杆菌/胞嘧啶脱氨酶肿瘤靶向性基因治疗系统的构建[J].中国肺癌杂志,2004,7(2):95-98. 被引量:20
  • 4Vaupel PW. Oxygenation of solid tumors in drug resistance in oncology. In: Teicher BA, ed. New York: Marcel Dekker,1993:53 - 85.
  • 5黄英,易成.厌氧菌——靶向性肿瘤基因治疗转移载体[J].国外医学(肿瘤学分册),2002,29(5):361-363. 被引量:2
  • 6Fujimori M, Sasaki T, Nakamura T, et al. Antitumor efficacy of anaerobic bacteria as delivery system for breast cancer gene therapy. Breast Cancer Research & Treatment, 2002; 76(Supplement 1 :S100) :1273.
  • 7Fujimori M,Amano J,Taniguchi S. The genus Bifidobacterium for cancer gene therapy. Curr Opin Drug Discov Devel,2002;5(2):200.
  • 8Yazawa K, Fujimori M, Amano J, et al. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther,2000;7(2):269.
  • 9Yazawa K, Fujimori M, Nakamura T, et al. Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors. Breast Cancer Research and Treatment, 2001; 66 (2): 165.

二级参考文献20

  • 1[2]Yazawa K, Fujimori M, Amano J, et al. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther,2000,7(2):269-274.
  • 2[3]Fujimori M, Amano J, Taniguchi S. The genus Bifidobacterium for cancer gene therapy. Curr Opin Drug Discov Devel,2002,5(2):200-203.
  • 3[4]Nuyts S, Van Mellaert L, Theys J, et al. Clostridium spores for tumor-specific drug delivery. Anticancer Drugs,2002,13(2):115-125.
  • 4Yazawa K,Fujimori M,Amano J,et al.Bifidobacterium longum as a delivery system for cancer gene therapy:selective localization and growth in hypoxic tumors[J].Cancer Gene Ther,2000,7(2):269-274.
  • 5Liu SC,Minton NP,Giaccia AJ,et al.Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis[J].Gene Ther,2002,9(4):291-296.
  • 6Schatzlein AG.Non-viral vectors in cancer gene therapy:principles and progress[J].Anticancer Drugs,2001,12(4):275-304.
  • 7Jain RK.The next frontier of molecular medicine:delivery of therapeutics[J].Nat Med,1998,4(6):655-657.
  • 8Semenza GL.Hypoxia,clonal selection and the role of HIF-1 in tumor progression[J].Crit Rev Biochem Mol Biol,2000,35(2):71-103.
  • 9Brown JM.Exploiting the hypoxic cancer cell:mechanisms and therapeutic strategies[J].Mol Med Today,2000,6(4):157-162.
  • 10Nuyts S,Van Mellaert L,Theys J,et al.Clostridium spores for tumor-specific drug delivery[J].Anticancer Drugs,2002,13(2):115-125.

共引文献20

同被引文献63

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部